/

Empresas

In

No verificado

InduPro, Inc.

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaOncologíaSalud

4 Comunicados de prensa

Ver todos los comunicados de prensa

12/08/2026

Industria

Biotecnología

Salud

Farmacéutica

Medicina - Varios

Oncología

InduPro Closes $77 Million Series B Financing and Doses First Patient in Phase 1 Study of Lead Oncology Program IDP-001

Fuente

Editor

1.00

0

27/05/2026

InduPro Therapeutics Appoints Amanda J. Redig, MD, PhD, as Chief Medical Officer

Fuente

Editor

1.00

0

07/01/2026

Oncología

Salud

Ciencia

Farmacéutica

Biotecnología

InduPro Therapeutics Announces Strategic Collaboration with Lilly to Develop First-in-Class Bispecific/Multispecific Oncology Therapeutics Using InduPro’s Proximity-Guided Platform

Fuente

Editor

1.00

0

10/12/2025

Mercado laboral

Oncología

Salud

Ciencia

Farmacéutica

Biotecnología

InduPro Therapeutics Announces Strategic Investment from Sanofi and a Research Collaboration to Advance a Novel Bispecific for Autoimmune Disorders

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0